|
NUSAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.83430000078033E-08 |
| Normal-vs-Stage2 |
1.718330E-02 |
| Normal-vs-Stage3 |
3.04589999999827E-06 |
| Normal-vs-Stage4 |
2.062200E-03 |
| Stage1-vs-Stage2 |
3.411000E-01 |
| Stage1-vs-Stage3 |
1.455330E-03 |
| Stage1-vs-Stage4 |
1.122410E-02 |
| Stage2-vs-Stage3 |
1.263010E-01 |
| Stage2-vs-Stage4 |
3.160300E-02 |
| Stage3-vs-Stage4 |
2.257800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63224989080391E-12 |
| Normal-vs-AfricanAmerican |
3.88110000000275E-05 |
| Normal-vs-Asian |
1.368000E-02 |
| Caucasian-vs-AfricanAmerican |
6.110800E-01 |
| Caucasian-vs-Asian |
2.147000E-01 |
| AfricanAmerican-vs-Asian |
1.499440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66477942542542E-12 |
| Normal-vs-Female |
1.89350000123767E-08 |
| Male-vs-Female |
5.585800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.38740000000948E-05 |
| Normal-vs-Extreme_Weight |
1.98640000004247E-07 |
| Normal-vs-Obese |
6.62929999784012E-08 |
| Normal-vs-Extreme_Obese |
2.815900E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.545800E-02 |
| Normal_Weight-vs-Obese |
9.683200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.891610E-02 |
| Extreme_Weight-vs-Obese |
2.256000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.162400E-01 |
| Obese-vs-Extreme_Obese |
3.764400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.023000E-03 |
| Normal-vs-Age(41-60Yrs) |
2.24376073276744E-13 |
| Normal-vs-Age(61-80Yrs) |
1.29120000025296E-07 |
| Normal-vs-Age(81-100Yrs) |
1.099790E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.482650E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.223500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.360000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.168500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.736200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.565800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.24829990367471E-10 |
| Normal-VS-Type2 PRCC |
1.47820000018228E-07 |
| Normal-VS-KIRP CIMP |
1.756660E-04 |
| Normal-VS-Unclassified PRCC |
1.03600000000981E-06 |
| Type1 PRCC-VS-Type2 PRCC |
6.262800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.793200E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.290640E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.60710000000264E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.787180E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.154100E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.61240000004803E-06 |
| Normal-vs-N1 |
2.92410000002352E-06 |
| Normal-vs-N2 |
5.971800E-02 |
| N0-vs-N1 |
1.038710E-03 |
| N0-vs-N2 |
7.155800E-02 |
| N1-vs-N2 |
6.337600E-01 |
|
|
